ReviewDiabetology & metabolic syndrome2026
Effects of high-oleic dietary interventions on cardiometabolic outcomes in adults: a GRADE-based systematic review and meta-analysis of randomized controlled trials.
Review in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiets rich in oleic acid have been proposed as a strategy to modify cardiometabolic risk. Evidence from randomized controlled trials (RCTs) remains inconsistent, particularly for glucose-related outcomes. To assess the effects of high-oleic dietary interventions compared with lower-oleic diets on lipid profiles, and glycemic indices in adults.
methodsPubMed, Embase, Web of Science, and Scopus were searched from inception to July 2025 in accordance with PRISMA 2020 guidelines. RCTs were eligible if the intervention diet provided at least 70% of total fatty acids as oleic acid, justified based on prior monounsaturated fat intervention literature, and differed from the comparator by at least 5% points. Random-effects meta-analyses were performed using weighted mean differences. Certainty of evidence was evaluated using the GRADE framework with outcome-specific assessments reported in a Summary of Findings table.
resultsTwenty-six trials involving 1,244 participants were included. High-oleic diets were associated with modest reductions in total cholesterol (WMD: -0.14; 95% CI: -0.28 to -0.01; I2 = 80.8%), and LDL-C (WMD: -0.13; 95% CI: -0.24 to -0.03; I2 = 64.6%). No significant effects were observed for HDL-C, triglycerides, fasting blood glucose, fasting insulin, or HOMA-IR. Lipid-lowering effects were more evident in trials with higher oleic acid proportions (≥ 80%).
conclusionsHigh-oleic dietary interventions result in small but consistent improvements in selected lipid outcomes without effects on glycemic indices. Benefits are dose-dependent and most pronounced when oleic acid constitutes a substantial portion of dietary fat. Absolute changes are modest, highlighting the complementary role of high-oleic diets in cardiometabolic risk management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.